Skip to content
OpenCapital
Get started

Nuvation Bio NUVB Payments To Acquire Machinery And Equipment

Other financials

Income statement

See full
Revenue$83.2M+2,599%
Gross profit$9.8M+1,340%
Operating income$3.9M+107%
Net income$5.4M+110%
EPS (diluted)$0.01+106%

Balance sheet

See full
Cash & equivalents$125.4M+161%
Total debt$57.2M+401%
Total equity$319.6M-23.8%
Total assets$610.2M+23.9%

Cash flow

See full
Operating cash flow$5.1M+112%
CapEx$48.0K-33.3%
Free cash flow$5.0M+112%

Valuation

See full
Market cap$2.25B+150%
Enterprise value$2.18B+154%
P/S15.7×-66.3×

Profitability

See full
Gross margin54.3%+39.5pp
Operating margin-105%-52.0pp
Net margin-102.1%-50.6pp
FCF margin-93.5%-45.2pp

Returns & leverage

See full
Return on equity-39.5%-15.8pp
Debt / equity0.2×+0.2×
Current ratio7.4×-1.6×

Where this comes from

Reported directly by Nuvation Bio in its filing.

Tagged under the XBRL concept us-gaap:PaymentsToAcquireMachineryAndEquipment.

The official record: Nuvation Bio’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Nuvation Bio's payments to acquire machinery and equipment.

Connect your AI assistant and see it in context, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Nuvation Bio's payments to acquire machinery and equipment?
Nuvation Bio (NUVB) reported payments to acquire machinery and equipment of $48K in Q1 2026.
How has Nuvation Bio's payments to acquire machinery and equipment changed year-over-year?
Nuvation Bio's payments to acquire machinery and equipment decreased by 33.3% year-over-year, from $72K to $48K.
What is the long-term trend for Nuvation Bio's payments to acquire machinery and equipment?
Over 3 years (2021 to 2025), Nuvation Bio's payments to acquire machinery and equipment has grown at a 7.9% compound annual growth rate (CAGR), from $282K to $354K.